Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Asset Writedowns and Impairment (2020 - 2025)

Innospec's Asset Writedowns and Impairment history spans 2 years, with the latest figure at -$3.8 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$3.8 million; the TTM value through Dec 2025 reached -$3.8 million, changed N/A, while the annual FY2025 figure was $19.1 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was -$3.8 million at Innospec, up from -$17.8 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at -$3.8 million in Q4 2025 and bottomed at -$3.8 million in Q4 2025.